Is Shanghai Junshi Biosciences Co Ltd Stock Halal?
Shariah Compliance Analysis of 688180.SS Stock
China Health Care Mid Cap
No. As of October 2026, Shanghai Junshi Biosciences Co Ltd (688180.SS) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Shanghai Junshi Biosciences Co Ltd does not pass Musaffa's business and financial screening criteria.
Shanghai Junshi Biosciences Co Ltd is a CN-based company operating in Biotechnology industry. Shanghai Junshi Biosciences Co Ltd is a China-based company primarily engaged in the discovery, development and commercialisation of innovative drugs. The Company’s products primarily include TUOYI toripalimab, recombinant humanized anti-tumor anti-B-and T-lymphocyte attenuator (BTLA) monoclonal Tifcemalimab, MINDEWEI deuremidevir hydrobromide tablets, JUNMAIKANG adalimumab, JUNSHIDA ongericimab, programmed death-1 (PD-1) monoclonal antibody subcutaneous injection formulation and others. The products are primarily used to treat malignant tumors, autoimmune diseases, chronic metabolic diseases, neurologic diseases and infectious diseases. The firm primarily operates its businesses in the domestic and American markets.
Shanghai Junshi Biosciences Co Ltd 688180.SS
Last Updated: Sep 30, 12:00 AM·SSE
688180.SS Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Shanghai Junshi Biosciences Co Ltd is classified as not halal.